| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |